Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131870) titled 'A prospective, single-center, open-label real-world study of budesonide enteric-coated capsules in the treatment of primary IgA nephropathy' on Sept. 7.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Ningbo Medical Centre Lihuili Hospital
Condition:
IgAN
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-07
Target Sample Size: Experimental Group:40;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=342122
Published by HT Digital Content Services with permission from Health Daily Digest....